Comparison between G R Infraprojects IPO and Tatva Chintan Pharma Chem IPO.
G R Infraprojects IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tatva Chintan Pharma Chem IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of G R Infraprojects IPO is up to ₹962.37 Cr whereas the issue size of the Tatva Chintan Pharma Chem IPO is up to ₹500.00 Cr. The final issue price of G R Infraprojects IPO is ₹837.00 per share and of Tatva Chintan Pharma Chem IPO is ₹1,083.00 per share.
| G R Infraprojects IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹828.00 per share | ₹1,073.00 per share |
| Issue Price (Upper) | ₹837.00 per share | ₹1,083.00 per share |
| Issue Price (Final) | ₹837.00 per share | ₹1,083.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹42.00 per share | |
| Market Lot Size | 17 shares | 13 shares |
| Fresh Issue Size | 0 shares | 20,77,562 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹225.00 Cr |
| OFS Issue Size | 1,15,08,704 shares | 25,39,242 shares |
| OFS Issue Size (Amount) | up to ₹962.37 Cr | up to ₹275.00 Cr |
| Issue Size Total | 1,15,08,704 shares | 46,16,804 shares |
| Issue Size Total (Amount) | up to ₹962.37 Cr | up to ₹500.00 Cr |
G R Infraprojects IPO opens on Jul 07, 2021, while Tatva Chintan Pharma Chem IPO opens on Jul 16, 2021. The closing date of G R Infraprojects IPO and Tatva Chintan Pharma Chem IPO is Jul 09, 2021, and Jul 20, 2021, respectively.
| G R Infraprojects IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Bid Date | Jul 06, 2021 | Jul 15, 2021 |
| Issue Open | Jul 07, 2021 | Jul 16, 2021 |
| Issue Close | Jul 09, 2021 | Jul 20, 2021 |
| Basis Of Allotment (Tentative) | Jul 14, 2021 | Jul 26, 2021 |
| Initiation of Refunds (Tentative) | Jul 15, 2021 | Jul 27, 2021 |
| Credit of Share (Tentative) | Jul 16, 2021 | Jul 28, 2021 |
| Listing date (Tentative) | Jul 19, 2021 | Jul 29, 2021 |
| Anchor Lockin End date 1 | Aug 13, 2021 | Aug 25, 2021 |
| Anchor Lockin End date 2 | Oct 12, 2021 | Oct 24, 2021 |
G R Infraprojects IPO P/E ratio is , as compared to Tatva Chintan Pharma Chem IPO P/E ratio of .
| G R Infraprojects IPO | Tatva Chintan Pharma Chem IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 88.04 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 86.54 | 79.17 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8092.87 Cr. | ₹2400.48 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the G R Infraprojects IPO Retail Individual Investors (RII) are offered 39,49,297 shares while in Tatva Chintan Pharma Chem IPO retail investors are offered 39,49,297 shares. Qualified Institutional Buyers (QIB) are offered 22,56,741 shares in G R Infraprojects IPO and 9,23,361 shares in Tatva Chintan Pharma Chem IPO.
| G R Infraprojects IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| Anchor Investor Reservation | 33,85,110 shares | 13,85,040 shares |
| Market Maker Reservation | ||
| QIB | 22,56,741 shares | 9,23,361 shares |
| NII | 16,92,556 shares | 6,92,521 shares |
| RII | 39,49,297 shares | 16,15,882 shares |
| Employee | 2,25,000 shares | |
| Others | ||
| Total | 1,15,08,704 shares | 46,16,804 shares |
G R Infraprojects IPO subscribed 102.58x in total, whereas Tatva Chintan Pharma Chem IPO subscribed 180.36x.
| G R Infraprojects IPO | Tatva Chintan Pharma Chem IPO | |
|---|---|---|
| QIB (times) | 168.58x | 185.23x |
| NII (times) | 238.04x | 512.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 12.57x | 35.35x |
| Employee (times) | 1.37x | |
| Other (times) | ||
| Total (times) | 102.58x | 180.36x |
